Adenosine A1 receptor agonist alleviates cerebral ischemia/reperfusion injury by inhibiting Nrf2/NLRP3 signaling‑mediated pyroptosis

Ming,Qiuli; Li,Ze; Tan,Jun; Li,Yanwei

doi:10.3892/etm.2025.12844

Adenosine A1 receptor agonist alleviates cerebral ischemia/reperfusion injury by inhibiting Nrf2/NLRP3 signaling‑mediated pyroptosis

Authors:
- Qiuli Ming
- Ze Li
- Jun Tan
- Yanwei Li
View Affiliations

Affiliations: Department of Neurology, Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan 453000, P.R. China, Department of Neurology, Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan 453000, P.R. China, Department of Neurology, Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan 453000, P.R. China
Published online on: March 13, 2025 https://doi.org/10.3892/etm.2025.12844
Article Number: 94

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate whether adenosine A1 receptor (A1R) agonists can alleviate cerebral ischemia/reperfusion (I/R) injury by inhibiting pyroptosis mediated through the nuclear factor erythroid 2‑related factor 2 (Nrf2)/NLR family pyrin domain containing 3 (NLRP3) signaling pathway. A total of 36 Sprague‑Dawley rats were randomly assigned to the following four groups: Sham (sham group), I/R (model group), adenosine A1 receptor agonist preconditioning [model + adenosine A1R agonist 2‑chloro‑N(6)‑cyclopentyladenosine] group and ML385 (model + adenosine A1R agonist group + Nrf2 pathway inhibitor group). A middle cerebral artery occlusion model was induced using the thread occlusion method. Neurological function was assessed using the Longa scale, brain infarction volume was determined through 2,3,5‑triphenyltetrazolium chloride staining, protein expression of Nrf2, NLRP3, caspase‑1, GSDMD and IL‑1β was assessed using western blotting, and the expression of Nrf2 and GSDMD was assessed using immunofluorescence. The findings revealed that adenosine A1R agonist improved neurological function and reduced infarct size. Mechanistically, this was found to be associated with the activation of the Nrf2/NLRP3 signaling pathway and the suppression of pyroptosis‑associated proteins (gasdermin D, caspase‑1 and IL‑1β) expression. Notably, the Nrf2 inhibitor ML385 reversed the aforementioned effects induced by the adenosine A1R agonist. These results suggest that adenosine A1R agonist can alleviate cerebral I/R injury in rats, potentially by modulating the Nrf2/NLRP3 signaling pathway to inhibit pyroptosis.

View Figures

View References

1	Feigin VL, Brainin M, Norrving B, Martins SO, Pandian J, Lindsay P, F Grupper M and Rautalin I: World stroke organization: Global stroke fact sheet 2025. Int J Stroke. 20:132–144. 2025.PubMed/NCBI View Article : Google Scholar
2	Liu D, Ji Q, Cheng Y, Liu M, Zhang B, Mei Q, Huan M and Zhou S: Cyclosporine A loaded brain targeting nanoparticle to treat cerebral ischemia/reperfusion injury in mice. J Nanobiotechnology. 20(256)2022.PubMed/NCBI View Article : Google Scholar
3	Guo XB, Deng X, Wang J, Qi Y, Zhao W and Guan S: HAX-1 interferes in assembly of NLRP3-ASC to block microglial pyroptosis in cerebral I/R injury. Cell Death Discov. 10:1–13. 2024.PubMed/NCBI View Article : Google Scholar
4	Zhang C, Ma Y, Zhao Y, Guo N, Han C, Wu Q, Mu C, Zhang Y, Tan S, Zhang J and Liu X: Systematic review of melatonin in cerebral ischemia-reperfusion injury: Critical role and therapeutic opportunities. Front Pharmacol. 15(1356112)2024.PubMed/NCBI View Article : Google Scholar
5	Wang K, Zhao H, Chen J, Yan LL, Zhao B, Chen Y, Dong YY, Li ZC and He Z: Toona sinensis fruit polyphenols alleviate cerebral ischemia-reperfusion injury in rats by inhibiting MAPK signaling pathways and NLRP3 inflammasome/pyroptosis. J Ethnopharmacol. 342(119375)2025.PubMed/NCBI View Article : Google Scholar
6	Gao P, Shi H, Jin X, Guo S, Zhou X and Gao W: Mechanism of astragaloside IV regulating NLRP3 through LOC102555978 to attenuate cerebral ischemia reperfusion induced microglia pyroptosis. Int Immunopharmacol. 131(111862)2024.PubMed/NCBI View Article : Google Scholar
7	He C, Zhao Y, Jiang X, Liang X, Yin L, Yin Z, Geng Y, Zhong Z, Song X, Zou Y, et al: Protective effect of Ketone musk on LPS/ATP-induced pyroptosis in J774A.1 cells through suppressing NLRP3/GSDMD pathway. Int Immunopharmacol. 71:328–335. 2019.PubMed/NCBI View Article : Google Scholar
8	Liu Y, Lei H, Zhang W, Xing Q, Liu R, Wu S, Liu Z, Yan Q, Li W, Liu X and Hu Y: Pyroptosis in renal inflammation and fibrosis: Current knowledge and clinical significance. Cell Death Dis. 14(472)2023.PubMed/NCBI View Article : Google Scholar
9	Li J, Teng D, Jia W, Gong L, Dong H, Wang C, Zhang L, Xu B, Wang W, Zhong L, et al: PLD2 deletion ameliorates sepsis-induced cardiomyopathy by suppressing cardiomyocyte pyroptosis via the NLRP3/caspase 1/GSDMD pathway. Inflamm Res. 73:1033–1046. 2024.PubMed/NCBI View Article : Google Scholar
10	Pinna A, Parekh P and Morelli M: Serotonin 5-HT1A receptors and their interactions with adenosine A2A receptors in Parkinson's disease and dyskinesia. Neuropharmacology. 226(109411)2023.PubMed/NCBI View Article : Google Scholar
11	Khan H, Kaur P, Singh TG, Grewal AK and Sood S: Adenosine as a key mediator of neuronal survival in cerebral ischemic injury. Neurochem Res. 47:3543–3555. 2022.PubMed/NCBI View Article : Google Scholar
12	Shi Y, Dai Q, Ji B, Huang L, Zhuang X, Mo Y and Wang J: Electroacupuncture pretreatment prevents cognitive impairment induced by cerebral ischemia-reperfusion via adenosine A1 receptors in rats. Front Aging Neurosci. 13(680706)2021.PubMed/NCBI View Article : Google Scholar
13	Li MZ, Zhao Y, Dai XY, Talukder M and Li JL: Lycopene ameliorates DEHP exposure-induced renal pyroptosis through the Nrf2/Keap-1/NLRP3/caspase-1 axis. J Nutr Biochem. 113(109266)2023.PubMed/NCBI View Article : Google Scholar
14	Fabera P, Parizkova M, Uttl L, Vondrakova K, Kubova H, Tsenov G and Mares P: Adenosine A1 receptor agonist 2-chloro-N6-cyclopentyladenosine and hippocampal excitability during brain development in rats. Front Pharmacol. 10(656)2019.PubMed/NCBI View Article : Google Scholar
15	Geng W, Cai L, Han K, Li D, Mo Y, Dai Q, Tang H, Zhang M, Akuetteh PDP, Balelang MF and Wang J: Electroacupuncture pretreatment alleviates cerebral ischemia-reperfusion injury by increasing GSK-3β phosphorylation level via adenosine a1 receptor. BioMed Res Int. 2020(6848450)2020.PubMed/NCBI View Article : Google Scholar
16	Fan GB, Li Y, Xu GS, Zhao AY, Jin HJ, Sun SQ and Qi SH: Propofol inhibits ferroptotic cell death through the Nrf2/Gpx4 signaling pathway in the mouse model of cerebral ischemia-reperfusion injury. Neurochem Res. 48:956–966. 2023.PubMed/NCBI View Article : Google Scholar
17	Chen L, Huang J, Yao ZM, Sun XR, Tong XH, Hu M, Zhang Y and Dong SY: Procyanidins alleviated cerebral ischemia/reperfusion injury by inhibiting ferroptosis via the Nrf2/HO-1 signaling pathway. Molecules. 28(3582)2023.PubMed/NCBI View Article : Google Scholar
18	Liu H, Li J, Jiang L, He J, Zhang H and Wang K: Dexmedetomidine pretreatment alleviates cerebral ischemia/reperfusion injury by inhibiting neuroinflammation through the JAK2/STAT3 pathway. Braz J Med Biol Res. 55(e12145)2022.PubMed/NCBI View Article : Google Scholar
19	Longa EZ, Weinstein PR, Carlson S and Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:84–91. 1989.PubMed/NCBI View Article : Google Scholar
20	Han W, Zhang E, Tian Y, Wang S and Chen Y: Reversible middle cerebral artery occlusion without craniectomy in rats. Exp Brain Res. 241:1471–1488. 2023.
21	Ramos-Zepeda G and Herrero JF: Interaction of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) and opioid receptors in spinal cord nociceptive reflexes. Life Sci. 93:233–239. 2013.PubMed/NCBI View Article : Google Scholar
22	Liu H, Sun Q, Ding Z, Shi W, Wang WH and Zhang C: Adenosine stimulates the basolateral 50 pS K+ channel in renal proximal tubule via adenosine-A1 receptor. Front Physiol. 14(1242975)2023.PubMed/NCBI View Article : Google Scholar
23	Schädlich IS, Winzer R, Stabernack J, Tolosa E, Magnus T and Rissiek B: The role of the ATP-adenosine axis in ischemic stroke. Semin Immunopathol. 45:347–365. 2023.PubMed/NCBI View Article : Google Scholar
24	Martire A, Lambertucci C, Pepponi R, Ferrante A, Benati N, Buccioni M, Dal Ben D, Marucci G, Klotz KN, Volpini R and Popoli P: Neuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia. J Neurochem. 149:211–230. 2019.PubMed/NCBI View Article : Google Scholar
25	Martí Navia A, Dal Ben D, Lambertucci C, Spinaci A, Volpini R, Marques-Morgado I, Coelho JE, Lopes LV, Marucci G and Buccioni M: Adenosine receptors as neuroinflammation modulators: Role of A1 Agonists and A2A Antagonists. Cells. 9(1739)2020.PubMed/NCBI View Article : Google Scholar
26	Liu J, Wang X, Wang X, Wang J, Ma Y, Cao Y and Zhang W: Chicken gasdermins mediate pyroptosis after the cleavage by caspases. Int J Biol Macromol. 270(132476)2024.PubMed/NCBI View Article : Google Scholar
27	Luo E, Li Z, Zhang S, Wen Y, Yang Z, Zeng H and Ding H: Hyperglycemia induces microglial pyroptosis by increasing oxygen extraction rate: Implication in neurological impairment during ischemic stroke. Mol Med Rep. 30(146)2024.PubMed/NCBI View Article : Google Scholar
28	Tuo QZ, Zhang ST and Lei P: Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications. Med Res Rev. 42:259–305. 2022.PubMed/NCBI View Article : Google Scholar
29	Tastan B, Arioz BI and Genc S: Targeting NLRP3 inflammasome with Nrf2 inducers in central nervous system disorders. Front Immunol. 13(865772)2022.PubMed/NCBI View Article : Google Scholar
30	She Y, Shao L, Jiao K, Sun R, Lang T, Long H, Tang Y, Zhang W, Ding C and Deng C: Glycosides of Buyang Huanwu decoction inhibits pyroptosis associated with cerebral ischemia-reperfusion through Nrf2-mediated antioxidant signaling pathway both in vivo and in vitro. Phytomedicine. 120(155001)2023.PubMed/NCBI View Article : Google Scholar
31	Cheng Y, Cheng L, Gao X, Chen S, Wu P, Wang C and Liu Z: Covalent modification of Keap1 at Cys77 and Cys434 by pubescenoside a suppresses oxidative stress-induced NLRP3 inflammasome activation in myocardial ischemia-reperfusion injury. Theranostics. 11:861–877. 2021.PubMed/NCBI View Article : Google Scholar
32	Shi M, Wang J, Bi F and Bai Z: Diosmetin alleviates cerebral ischemia-reperfusion injury through Keap1-mediated Nrf2/ARE signaling pathway activation and NLRP3 inflammasome inhibition. Environ Toxicol. 37:1529–1542. 2022.PubMed/NCBI View Article : Google Scholar
33	Liston TE, Hama A, Boltze J, Poe RB, Natsume T, Hayashi I, Takamatsu H, Korinek WS and Lechleiter JD: Adenosine A1R/A3R (adenosine A1 and A3 receptor) agonist AST-004 reduces brain infarction in a nonhuman primate model of stroke. Stroke. 53:238–248. 2022.PubMed/NCBI View Article : Google Scholar
34	Zhong M, Song WL, Xu YC, Ye Y and Feng LY: Paeoniflorin ameliorates ischemic neuronal damage in vitro via adenosine A1 receptor-mediated transactivation of epidermal growth factor receptor. Acta Pharmacol Sin. 36:298–310. 2015.PubMed/NCBI View Article : Google Scholar
35	Rabie MA, Ibrahim HI, Nassar NN and Atef RM: Adenosine A1 receptor agonist, N6-cyclohexyladenosine, attenuates Huntington's disease via stimulation of TrKB/PI3K/Akt/CREB/BDNF pathway in 3-nitropropionic acid rat model. Chem Biol Interact. 369(110288)2023.PubMed/NCBI View Article : Google Scholar
36	Guo Y, Mao M, Li Q, Yu X and Zhou L: Extracts of Ginkgo flavonoids and ginkgolides improve cerebral ischaemia-reperfusion injury through the PI3K/Akt/Nrf2 signalling pathway and multicomponent in vivo processes. Phytomedicine. 99(154028)2022.PubMed/NCBI View Article : Google Scholar